140 related articles for article (PubMed ID: 10694682)
1. Maternal serum second trimester AFP and hCG in pregnancies with placenta previa.
Heikkilä A; Heinonen S; Kirkinen P
Prenat Diagn; 2000 Feb; 20(2):100-2. PubMed ID: 10694682
[TBL] [Abstract][Full Text] [Related]
2. Intrahepatic cholestasis of pregnancy has no effect on maternal serum second trimester alpha-fetoprotein and hCG.
Eloranta ML; Heinonen S; Kirkinen P
Acta Obstet Gynecol Scand; 2000 Jul; 79(7):548-52. PubMed ID: 10929953
[TBL] [Abstract][Full Text] [Related]
3. Obstetrical complications associated with abnormal maternal serum markers analytes.
Gagnon A; Wilson RD;
J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
[TBL] [Abstract][Full Text] [Related]
4. Maternal smoking: age distribution, levels of alpha-fetoprotein and human chorionic gonadotrophin, and effect on detection of Down syndrome pregnancies in second-trimester screening.
Crossley JA; Aitken DA; Waugh SM; Kelly T; Connor JM
Prenat Diagn; 2002 Mar; 22(3):247-55. PubMed ID: 11920904
[TBL] [Abstract][Full Text] [Related]
5. Second Trimester Biochemical Markers as Possible Predictors of Pathological Placentation: A Retrospective Case-Control Study.
Berezowsky A; Pardo J; Ben-Zion M; Wiznitzer A; Aviram A
Fetal Diagn Ther; 2019; 46(3):187-192. PubMed ID: 30726846
[TBL] [Abstract][Full Text] [Related]
6. Preliminary evidence for associations between second-trimester human chorionic gonadotropin and unconjugated oestriol levels with pregnancy outcome in Down syndrome pregnancies.
Benn PA
Prenat Diagn; 1998 Apr; 18(4):319-24. PubMed ID: 9602476
[TBL] [Abstract][Full Text] [Related]
7. Analysis of maternal serum alpha-fetoprotein and free beta human chorionic gonadotrophin in the first trimester: implications for Down's syndrome screening.
Berry E; Aitken DA; Crossley JA; Macri JN; Connor JM
Prenat Diagn; 1995 Jun; 15(6):555-65. PubMed ID: 7544898
[TBL] [Abstract][Full Text] [Related]
8. Effect of in vitro fertilization on human chorionic gonadotropin serum concentrations and Down's syndrome screening.
Heinonen S; Ryynänen M; Kirkinen P; Hippeläinen M; Saarikoski S
Fertil Steril; 1996 Sep; 66(3):398-403. PubMed ID: 8751737
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of combining maternal serum alpha-fetoprotein and hCG in a second-trimester screening program for Down syndrome.
Mooney RA; Peterson CJ; French CA; Saller DN; Arvan DA
Obstet Gynecol; 1994 Aug; 84(2):298-303. PubMed ID: 7518896
[TBL] [Abstract][Full Text] [Related]
10. Dependence of maternal serum [AFP]/[hCG] median ratios on age of gestation: comparison of trisomy 21 to euploid pregnancies.
Marcus-Braun N; Birk O; Manor E; Segal D; Harari G; Toma I; Shalev S; Borochowitz ZU; Yaron Y; Sharony R; Itzhaky D; Shtoyerman R; Appelman Z; Braun G
Prenat Diagn; 2009 Dec; 29(12):1130-4. PubMed ID: 19777489
[TBL] [Abstract][Full Text] [Related]
11. The use of free beta-hCG in antenatal screening for Down's syndrome.
Wald N; Densem J; Stone R; Cheng R
Br J Obstet Gynaecol; 1993 Jun; 100(6):550-7. PubMed ID: 7687460
[TBL] [Abstract][Full Text] [Related]
12. Mid-trimester maternal serum AFP and hCG as markers of preterm and term adverse pregnancy outcomes.
Tancrède S; Bujold E; Giguère Y; Renald MH; Girouard J; Forest JC
J Obstet Gynaecol Can; 2015 Feb; 37(2):111-6. PubMed ID: 25767942
[TBL] [Abstract][Full Text] [Related]
13. Correlation of ultrasound findings and biochemical markers in the second trimester of pregnancy in fetuses with trisomy 21.
Souter VL; Nyberg DA; El-Bastawissi A; Zebelman A; Luthhardt F; Luthy DA
Prenat Diagn; 2002 Mar; 22(3):175-82. PubMed ID: 11920888
[TBL] [Abstract][Full Text] [Related]
14. Detection of maternal serum hCG glycoform variants in the second trimester of pregnancies affected by Down syndrome using a lectin immunoassay.
Talbot JA; Spencer K; Abushoufa RA
Prenat Diagn; 2003 Jan; 23(1):1-5. PubMed ID: 12533803
[TBL] [Abstract][Full Text] [Related]
15. Maternal serum unconjugated oestriol and human chorionic gonadotrophin levels in twin pregnancies: implications for screening for Down's syndrome.
Wald N; Cuckle H; Wu TS; George L
Br J Obstet Gynaecol; 1991 Sep; 98(9):905-8. PubMed ID: 1716981
[TBL] [Abstract][Full Text] [Related]
16. Outcome validation of the Beckman Coulter access analyzer in a second-trimester Down syndrome serum screening application.
MacRae AR; Gardner HA; Allen LC; Tokmakejian S; Lepage N
Clin Chem; 2003 Jan; 49(1):69-76. PubMed ID: 12507962
[TBL] [Abstract][Full Text] [Related]
17. Second-trimester Down syndrome maternal serum screening in twin pregnancies: impact of chorionicity.
Muller F; Dreux S; Dupoizat H; Uzan S; Dubin MF; Oury JF; Dingeon B; Dommergues M
Prenat Diagn; 2003 Apr; 23(4):331-5. PubMed ID: 12673641
[TBL] [Abstract][Full Text] [Related]
18. Correlation between elevated maternal serum alpha-fetoprotein and ischemic placental disease: a retrospective cohort study.
Dai X; Zhang H; Wu B; Ning W; Chen Y; Chen Y
Clin Exp Hypertens; 2023 Dec; 45(1):2175848. PubMed ID: 36849437
[TBL] [Abstract][Full Text] [Related]
19. Second-trimester maternal serum screening for Down syndrome in in vitro fertilization pregnancies.
Rice JD; McIntosh SF; Halstead AC
Prenat Diagn; 2005 Mar; 25(3):234-8. PubMed ID: 15791658
[TBL] [Abstract][Full Text] [Related]
20. Alteration in age-specific risks for chromosomal trisomy by maternal serum alpha-fetoprotein and human chorionic gonadotropin screening.
Miller CH; O'Brien TJ; Chatelain S; Butler BB; Quirk JG
Prenat Diagn; 1991 Mar; 11(3):153-8. PubMed ID: 1710067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
